Ruling On Lab Rodents Could Reduce Oversight Of All Animal Sites

Ruling On Lab Rodents Could Reduce Oversight Of All Animal Sites WASHINGTON--Animal rights activists are pleased about a federal judge's ruling last month that the United States Department of Agriculture acted in an "arbitrary and capricious" manner in excluding rats, mice, and birds from its interpretation of a federal law meant to protect research animals. But the judge's favorable decision in their suit could result in less-frequent inspections of research facilities housing these and othe

Written byJeffrey Mervis
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

On January 8, in the U.S. District Court here, Judge Charles Richey ruled that the Agriculture Department had no valid reason to omit from inspection, called for under the 1971 amended version of the Animal Welfare Act, an estimated 15 to 20 million rodents and birds--representing 85 percent of all animals used in research labs across the country. The law requires USDA to register and inspect regularly any institution or company that uses, breeds, or cares for laboratory animals. He ordered department officials to review their decision--made in 1971 because the department wished to direct its limited resources toward the well-being of such higher-order animals as dogs, cats, and primates--as a first step in issuing regulations to cover rodents and birds.

USDA currently oversees some 7,600 sites, including colleges, companies, and carriers of research animals, which it inspects an average of 1.5 times a year. In addition, institutions that receive ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies